期刊文献+

雌激素膜受体GPR30对NE诱导的新生大鼠心肌细胞肥大作用的实验研究

Experimental Study of the Effect of Membranous Estrogen Receptor GPR30 on the Norepinephrine-induced Myocardial Cell Enlargement of Newborn Mice
下载PDF
导出
摘要 目的探讨雌激素膜受体GPR30对去甲肾上腺素(NE)诱导的新生大鼠心肌细胞肥大的作用。方法培养的新生大鼠心肌细胞分为空白对照组、NE诱导的心肌细胞肥大组(模型组)和在模型组的基础上应用不同浓度GPR30特异性激动剂(G-1)处理的实验组,G-1的浓度分别为10pmol/L、100pmol/L、1nmol/L、10nmol/L。应用免疫荧光细胞化学技术检测GPR30在心肌细胞内的表达、MTT和PI-hoechst染色对各组心肌细胞增值凋亡情况进行分析。结果 GPR30在心肌细胞内大量表达,属于胞膜受体;它可抑制NE诱导心肌细胞的肥大,且具有浓度依赖性。结论 GPR30可抑制去甲肾上腺素所诱导的心肌细胞肥大。 Objective To explore the effect of membranous estrogen receptor GPR30 on the norepinephrine-induced myocardial cell enlargement of newborn mice. Methods Myocardial cells of newborn mice were cultured and then divided into control group, myocardial cell enlargement group (model group) and the groups with GPR30 agonist probe G-1 treatment based on the model. G-lconcentration was 10 pmol/L, 100 pmol/L, 1 nmol/L and 10 nmol/L, respectively. The expression of GPR30 in the myocardial cells of newborn mice was detected by immunofluorescence technique. Their profiferation and apoptosis were analyzed after MTT and PI-hoechst dying. Results GPR30 was a membranous receptor and expressed in a massive manner. It could inhibit the norepinephrine-induced myocardial cell enlargement of new born mice in the concentration-dependent manner. Conclusion GPR30 can inhibit the norepinephrine-induced myocardial cell enlargement of newborn mice.
出处 《临床医学工程》 2011年第2期173-175,共3页 Clinical Medicine & Engineering
基金 陕西省自然科学基金资助(2007C224)
关键词 GPR30 G-1 去甲肾上腺素 心肌细胞肥大 GPR30 G-l Norepinephrine Myocardial cell enlargement
  • 相关文献

参考文献15

  • 1Ansar AS, Penhale WJ, Talal N, et al. Sex hormones, immune responses, and autoimmune diseases: mechanisms of sex hormone action [J]. Am JPathol, 1985, 121 (3) :531-551.
  • 2Rossouw JE. Hormones, genetic factors, and gender differences in cardiovascular disease [J]. Cardiovasc Res, 200:2, 53 (3) : 550-557.
  • 3Wu CH, Liu JY, Wu JP, et al. 17beta-estradiol reduces cardiac hy pertrophy mediated through the up-regulation of PI3K/Akt and the suppression of calcineurin/NF-A33 signaling pathways in rats [J]. Life Sci, 2005, 78(4) : 347-356.
  • 4Gosse P. Left ventricular hypertrophy as a predictor of cardiovascular risk [J]. JHypertens Suppl, 2005, 23 (1) : $27-33.
  • 5Agabiti-Rosei E, Muiesan ML. Left ventricular hypertrophy and heart failure in women [J]. J Hypertens Suppl, 2002, 20 (2) : $34-38.
  • 6Miya Y, Sumino H, Ichikawa S, et al. Effects of hormone replacement therapy on left ventricular hypertrophy and growth-promoting factors in hypertensive postmenopausal women [J]. Hypertens Res, 2002, 25(2) : 153-159.
  • 7Modena MG, Muia N Jr, Aveta P, et al. Effects of transdermal 17beta-estradiol on left ventricular anatomy and performance in hypertensive women [J]. Hypertension, 1999, 34 (5) : 1041-1046.
  • 8Van Eickels M, Grohe C, Cleutjens JP, et al. 17beta-estradiol attenuates the development of pressure-overload hypertrophy [J]. Circulation, 2001, 104(12) : 1419-1423.
  • 9Haas E, Meyer MR, Schurr U, et al. Differential effects of 17beta-estradiol on function and expression of estrogen receptor alpha, estrogen re ceptor beta, and GPR30 in arteries and veins of patients with atherosclerosis [J]. Hypertension, 2007, 49 (6) : 1358-1363.
  • 10Lindsey SH, Cohen JA, Brosnihan KB, et al. Chronic treatment with the G protein-coupled receptor 30 agonist G-1 decreases blood pres- sure in ovarieetomized mRen2. Lewis rats [J]. Endocrinology, 2009, 150 (8) :3753-3758.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部